567 related articles for article (PubMed ID: 35968268)
1. Advancement of Organoid Technology in Regenerative Medicine.
Arjmand B; Rabbani Z; Soveyzi F; Tayanloo-Beik A; Rezaei-Tavirani M; Biglar M; Adibi H; Larijani B
Regen Eng Transl Med; 2023; 9(1):83-96. PubMed ID: 35968268
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell and Spatial Analysis of Emergent Organoid Platforms.
Kumar A; Cai S; Allam M; Henderson S; Ozbeyler M; Saiontz L; Coskun AF
Methods Mol Biol; 2023; 2660():311-344. PubMed ID: 37191807
[TBL] [Abstract][Full Text] [Related]
3. Plasma-derived extracellular matrix for xenofree and cost-effective organoid modeling for hepatocellular carcinoma.
El-Derby AM; Khedr MA; Ghoneim NI; Gabr MM; Khater SM; El-Badri N
J Transl Med; 2024 May; 22(1):487. PubMed ID: 38773585
[TBL] [Abstract][Full Text] [Related]
4. Challenges for the Applications of Human Pluripotent Stem Cell-Derived Liver Organoids.
Chang M; Bogacheva MS; Lou YR
Front Cell Dev Biol; 2021; 9():748576. PubMed ID: 34660606
[TBL] [Abstract][Full Text] [Related]
5. Insights on Three Dimensional Organoid Studies for Stem Cell Therapy in Regenerative Medicine.
Mulaudzi PE; Abrahamse H; Crous A
Stem Cell Rev Rep; 2024 Feb; 20(2):509-523. PubMed ID: 38095787
[TBL] [Abstract][Full Text] [Related]
6. Current Challenges Associated with the Use of Human Induced Pluripotent Stem Cell-Derived Organoids in Regenerative Medicine.
Lee H; Son MY
Int J Stem Cells; 2021 Feb; 14(1):9-20. PubMed ID: 33632980
[TBL] [Abstract][Full Text] [Related]
7. Advancing Intestinal Organoid Technology Toward Regenerative Medicine.
Nakamura T; Sato T
Cell Mol Gastroenterol Hepatol; 2018; 5(1):51-60. PubMed ID: 29204508
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in organoid engineering: A comprehensive review.
Unagolla JM; Jayasuriya AC
Appl Mater Today; 2022 Dec; 29():. PubMed ID: 38264423
[TBL] [Abstract][Full Text] [Related]
9. Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine.
Novelli G; Spitalieri P; Murdocca M; Centanini E; Sangiuolo F
Front Cell Dev Biol; 2022; 10():1059579. PubMed ID: 36699015
[TBL] [Abstract][Full Text] [Related]
10. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.
Grassi L; Alfonsi R; Francescangeli F; Signore M; De Angelis ML; Addario A; Costantini M; Flex E; Ciolfi A; Pizzi S; Bruselles A; Pallocca M; Simone G; Haoui M; Falchi M; Milella M; Sentinelli S; Di Matteo P; Stellacci E; Gallucci M; Muto G; Tartaglia M; De Maria R; Bonci D
Cell Death Dis; 2019 Feb; 10(3):201. PubMed ID: 30814510
[TBL] [Abstract][Full Text] [Related]
11. Bioengineering toolkits for potentiating organoid therapeutics.
Park S; Cho SW
Adv Drug Deliv Rev; 2024 May; 208():115238. PubMed ID: 38447933
[TBL] [Abstract][Full Text] [Related]
12. Organoid Models of Heart Diseases: Find a New Channel in Improvements of Cardiac Regenerative Medicine.
Jasim SA; Bokov DO; Suksatan W; Alsaikhan F; Jawad MA; Sharma SK; Chupradit S; Thangavelu L
Curr Med Chem; 2023; 30(33):2726-3742. PubMed ID: 36281859
[TBL] [Abstract][Full Text] [Related]
13. Biomaterials for intestinal organoid technology and personalized disease modeling.
Hirota A; AlMusawi S; Nateri AS; Ordóñez-Morán P; Imajo M
Acta Biomater; 2021 Sep; 132():272-287. PubMed ID: 34023456
[TBL] [Abstract][Full Text] [Related]
14. Mini-organs forum: how to advance organoid technology to organ transplant community.
Berishvili E; Casiraghi F; Amarelli C; Scholz H; Piemonti L; Berney T; Montserrat N
Transpl Int; 2021 Sep; 34(9):1588-1593. PubMed ID: 34448263
[TBL] [Abstract][Full Text] [Related]
15. Synthetic scaffolds for 3D cell cultures and organoids: applications in regenerative medicine.
Marchini A; Gelain F
Crit Rev Biotechnol; 2022 May; 42(3):468-486. PubMed ID: 34187261
[TBL] [Abstract][Full Text] [Related]
16. Ethical and regulatory issues of stem cell-derived 3-dimensional organoid and tissue therapy for personalised regenerative medicine.
Harris AR; Walker MJ; Gilbert F
BMC Med; 2022 Dec; 20(1):499. PubMed ID: 36575403
[TBL] [Abstract][Full Text] [Related]
17. Stem Cells and Organoid Technology in Precision Medicine in Inflammation: Are We There Yet?
Tran F; Klein C; Arlt A; Imm S; Knappe E; Simmons A; Rosenstiel P; Seibler P
Front Immunol; 2020; 11():573562. PubMed ID: 33408713
[TBL] [Abstract][Full Text] [Related]
18. Design by Nature: Emerging Applications of Native Liver Extracellular Matrix for Cholangiocyte Organoid-Based Regenerative Medicine.
Willemse J; van der Laan LJW; de Jonge J; Verstegen MMA
Bioengineering (Basel); 2022 Mar; 9(3):. PubMed ID: 35324799
[TBL] [Abstract][Full Text] [Related]
19. The Translational Application of Hydrogel for Organoid Technology: Challenges and Future Perspectives.
Ma P; Chen Y; Lai X; Zheng J; Ye E; Loh XJ; Zhao Y; Parikh BH; Su X; You M; Wu YL; Li Z
Macromol Biosci; 2021 Oct; 21(10):e2100191. PubMed ID: 34263547
[TBL] [Abstract][Full Text] [Related]
20. Applications of Bioengineered 3D Tissue and Tumor Organoids in Drug Development and Precision Medicine: Current and Future.
Devarasetty M; Mazzocchi AR; Skardal A
BioDrugs; 2018 Feb; 32(1):53-68. PubMed ID: 29383499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
